Prolonged monitoring of ethinyl estradiol and levonorgestrel levels confirms an altered pharmacokinetic profile in obese oral contraceptives users

Contraception

Volumn 87, Issue 2, 2013, Pages 220-226

  Edelman, Alison B ^a   Cherala, Ganesh ^a,b   Munar, Myrna Y ^b   Dubois, Barent ^b   McInnis, Martha ^a   Stanczyk, Frank Z ^c   Jensen, Jeffrey T ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON STATE UNIVERSITY   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Body weight; Obesity; Oral contraceptives; Pharmacokinetics

Indexed keywords

ESTRADIOL; ETHINYLESTRADIOL PLUS LEVONORGESTREL; PROGESTERONE;

ACCURACY; ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; BODY MASS; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DOSE REGIMEN; DRUG HALF LIFE; DRUG MONITORING; ESTRADIOL BLOOD LEVEL; FEMALE; HUMAN; OBESITY; ORAL CONTRACEPTION; OUTPATIENT; OVARY FOLLICLE; OVARY FUNCTION; OVULATION; PROGESTERONE BLOOD LEVEL; SCORING SYSTEM; STEADY STATE; TRANSVAGINAL ECHOGRAPHY; UTERINE CERVIX MUCUS;

ADOLESCENT; ADULT; BODY MASS INDEX; COHORT STUDIES; CONTRACEPTIVES, ORAL, COMBINED; ESTRADIOL; ETHINYL ESTRADIOL; FEMALE; HUMANS; LEVONORGESTREL; OBESITY; PROGESTERONE; PROSPECTIVE STUDIES;

EID: 84872128885     PISSN: 00107824     EISSN: 18790518     Source Type: Journal    
DOI: 10.1016/j.contraception.2012.10.008     Document Type: Article

References (14)

1. A. Edelman Society of Family Planning clinical guidelines: contraceptive considerations in obese women Contraception 80 2009 583 590
2. The practice committee for American Society for Reproductive Medicine Obesity and reproduction: an educational bulletin Fertil Steril 90 2008 S21 S29
3. C.L. Westhoff, A.T. Torgal, E.R. Mayeda, N. Shimoni, F.Z. Stanczyk, and M.C. Pike Predictors of noncompliance in an oral contraceptive clinical trial Contraception 85 2012 465 469
4. C.L. Westhoff, A.H. Torgal, and E.R. Mayeda Ovarian suppression in normal-weight and obese women during oral contraceptive use: a randomized controlled trial Obstet Gynecol 116 2010 275 283
5. D.P. Nicolau Predicting antibacterial response from pharmacodynamic and pharmacokinetic profiles Infection 29 Suppl. 2 2001 11 15 (Pubitemid 34001314)
6. W. Kuhnz, H. Blode, and H. Zimmerman Pharmacokinetics of exogenous natural and synthetic estrogens and antiestrogens M. Oettel, E. Schillinger, Estrogens and antiestrogens II: pharmacology and clinical application of estrogens and antiestrogens 1999 Springer NY 261 322
7. K. Fotherby Pharmacokinetics of gestagens: some problems Am J Obstet Gynecol 163 1990 323 328 (Pubitemid 20251643)
8. C.L. Westhoff, A.H. Torgal, E.R. Mayeda, M.C. Pike, and F.Z. Stanczyk Pharmacokinetics of a combined oral contraceptive in obese and normal-weight women Contraception 81 2010 474 480
9. A.B. Edelman, N.E. Carlson, and G. Cherala Impact of obesity on oral contraceptive pharmacokinetics and hypothalamic-pituitary-ovarian activity Contraception 80 2009 119 127
10. WHO laboratory manual for the examination of human sperm and sperm-cervical mucus interaction 1992 Cambridge University Press Cambridge
11. F.Z. Stanczyk, M. Hiroi, U. Goebelsmann, P.F. Brenner, M.E. Lumkin, and D.R. Mishell Jr. Radioimmunoassay of serum d-norgestrel in women following oral and intravaginal administration Contraception 12 1975 279 298
12. M. Rowland, and T.N. Tozer Clinical pharmacokinetics: concepts and applications 1980 Lea & Febiger Philadelphia
13. Administration FDA Guidance for industry: exposure-response relationships - study design, data analysis, and regulatory applications 2003 US Department of Health and Human Services Washington, DC http://www.fda.gov/downloads/drugs/ guidancecomplianceregulatoryinformation/guidances/ucm072109.pdf
14. A. Glasier, S.T. Cameron, and D. Blithe Can we identify women at risk of pregnancy despite using emergency contraception? Data from randomized trials of ulipristal acetate and levonorgestrel Contraception 84 2011 363 367